APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Antithrombotic Coatings

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Antithrombotic Coatings Market Outlook and Growth Opportunities 2026

2 January 2026193 pages

Choose your research edition.

Industry ResearchMedical Antithrombotic Coatings Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Antithrombotic Coatings Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Medical Antithrombotic Coatings Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Antithrombotic Coatings Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Antithrombotic Coatings Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Medical Antithrombotic Coatings market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Antithrombotic Coatings is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Antithrombotic Coatings is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Antithrombotic Coatings is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Antithrombotic Coatings market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Antithrombotic Coatings market include Thermal Spray Technologies, Surmodics, Surface Solutions Group, Specialty Coating Systems (SCS), Hydromer, Harland Medical Systems, Coatings2Go and Biocoat, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medical Antithrombotic Coatings market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Antithrombotic Coatings and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Antithrombotic Coatings sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Antithrombotic Coatings market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Antithrombotic Coatings Segment by Company

Thermal Spray Technologies

Surmodics

Surface Solutions Group

Specialty Coating Systems (SCS)

Hydromer

Harland Medical Systems

Coatings2Go

Biocoat

Medical Antithrombotic Coatings Segment by Type

Phosphorylcholine

PEG Coating

Heparin Coating

Other

Medical Antithrombotic Coatings Segment by Application

Medical Devices

Hemodialysis Tubing

Vascular Stents

Other

Medical Antithrombotic Coatings Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Antithrombotic Coatings status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medical Antithrombotic Coatings market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Antithrombotic Coatings significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Antithrombotic Coatings competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Antithrombotic Coatings market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Antithrombotic Coatings and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Antithrombotic Coatings.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Antithrombotic Coatings market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Antithrombotic Coatings industry.

Chapter 3: Detailed analysis of Medical Antithrombotic Coatings manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medical Antithrombotic Coatings in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medical Antithrombotic Coatings in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Antithrombotic Coatings Industry Trends Table 2. Medical Antithrombotic Coatings Industry Drivers Table 3. Medical Antithrombotic Coatings Industry Opportunities and Challenges Table 4. Medical Antithrombotic Coatings Industry Restraints Table 5. Global Medical Antithrombotic Coatings Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Antithrombotic Coatings Revenue Share by Company (2021-2026) Table 7. Global Medical Antithrombotic Coatings Sales Volume by Company (t) & (2021-2026) Table 8. Global Medical Antithrombotic Coatings Sales Volume Share by Company (2021-2026) Table 9. Global Medical Antithrombotic Coatings Average Price (USD/kg) of Company (2021-2026) Table 10. Global Medical Antithrombotic Coatings Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medical Antithrombotic Coatings Key Company Manufacturing Base & Headquarters Table 12. Global Medical Antithrombotic Coatings Company, Product Type & Application Table 13. Global Medical Antithrombotic Coatings Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Antithrombotic Coatings by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Phosphorylcholine Table 18. Significant Companies of PEG Coating Table 19. Significant Companies of Heparin Coating Table 20. Significant Companies of Other Table 21. Global Medical Antithrombotic Coatings Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 22. Global Medical Antithrombotic Coatings Sales Volume by Type (2021-2026) & (t) Table 23. Global Medical Antithrombotic Coatings Sales Volume by Type (2027-2032) & (t) Table 24. Global Medical Antithrombotic Coatings Sales Volume Share by Type (2021-2026) Table 25. Global Medical Antithrombotic Coatings Sales Volume Share by Type (2027-2032) Table 26. Global Medical Antithrombotic Coatings Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Antithrombotic Coatings Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Medical Antithrombotic Coatings Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Medical Antithrombotic Coatings Sales Value Share by Type (2021-2026) Table 30. Global Medical Antithrombotic Coatings Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Medical Devices Table 32. Significant Companies of Hemodialysis Tubing Table 33. Significant Companies of Vascular Stents Table 34. Significant Companies of Other Table 35. Global Medical Antithrombotic Coatings Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 36. Global Medical Antithrombotic Coatings Sales Volume by Application (2021-2026) & (t) Table 37. Global Medical Antithrombotic Coatings Sales Volume by Application (2027-2032) & (t) Table 38. Global Medical Antithrombotic Coatings Sales Volume Share by Application (2021-2026) Table 39. Global Medical Antithrombotic Coatings Sales Volume Share by Application (2027-2032) Table 40. Global Medical Antithrombotic Coatings Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Medical Antithrombotic Coatings Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Medical Antithrombotic Coatings Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Medical Antithrombotic Coatings Sales Value Share by Application (2021-2026) Table 44. Global Medical Antithrombotic Coatings Sales Value Share by Application (2027-2032) Table 45. Global Medical Antithrombotic Coatings Sales by Region: 2021 VS 2025 VS 2032 (t) Table 46. Global Medical Antithrombotic Coatings Sales by Region (2021-2026) & (t) Table 47. Global Medical Antithrombotic Coatings Sales Market Share by Region (2021-2026) Table 48. Global Medical Antithrombotic Coatings Sales by Region (2027-2032) & (t) Table 49. Global Medical Antithrombotic Coatings Sales Market Share by Region (2027-2032) Table 50. Global Medical Antithrombotic Coatings Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Medical Antithrombotic Coatings Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Medical Antithrombotic Coatings Sales Value Share by Region (2021-2026) Table 53. Global Medical Antithrombotic Coatings Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Medical Antithrombotic Coatings Sales Value Share by Region (2027-2032) Table 55. Global Medical Antithrombotic Coatings Market Average Price (USD/kg) by Region (2021-2026) Table 56. Global Medical Antithrombotic Coatings Market Average Price (USD/kg) by Region (2027-2032) Table 57. Global Medical Antithrombotic Coatings Sales by Country: 2021 VS 2025 VS 2032 (t) Table 58. Global Medical Antithrombotic Coatings Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Medical Antithrombotic Coatings Sales by Country (2021-2026) & (t) Table 60. Global Medical Antithrombotic Coatings Sales Market Share by Country (2021-2026) Table 61. Global Medical Antithrombotic Coatings Sales by Country (2027-2032) & (t) Table 62. Global Medical Antithrombotic Coatings Sales Market Share by Country (2027-2032) Table 63. Global Medical Antithrombotic Coatings Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Medical Antithrombotic Coatings Sales Value Market Share by Country (2021-2026) Table 65. Global Medical Antithrombotic Coatings Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Medical Antithrombotic Coatings Sales Value Market Share by Country (2027-2032) Table 67. Thermal Spray Technologies Company Information Table 68. Thermal Spray Technologies Business Overview Table 69. Thermal Spray Technologies Medical Antithrombotic Coatings Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 70. Thermal Spray Technologies Medical Antithrombotic Coatings Product Portfolio Table 71. Thermal Spray Technologies Recent Development Table 72. Surmodics Company Information Table 73. Surmodics Business Overview Table 74. Surmodics Medical Antithrombotic Coatings Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 75. Surmodics Medical Antithrombotic Coatings Product Portfolio Table 76. Surmodics Recent Development Table 77. Surface Solutions Group Company Information Table 78. Surface Solutions Group Business Overview Table 79. Surface Solutions Group Medical Antithrombotic Coatings Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 80. Surface Solutions Group Medical Antithrombotic Coatings Product Portfolio Table 81. Surface Solutions Group Recent Development Table 82. Specialty Coating Systems (SCS) Company Information Table 83. Specialty Coating Systems (SCS) Business Overview Table 84. Specialty Coating Systems (SCS) Medical Antithrombotic Coatings Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 85. Specialty Coating Systems (SCS) Medical Antithrombotic Coatings Product Portfolio Table 86. Specialty Coating Systems (SCS) Recent Development Table 87. Hydromer Company Information Table 88. Hydromer Business Overview Table 89. Hydromer Medical Antithrombotic Coatings Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 90. Hydromer Medical Antithrombotic Coatings Product Portfolio Table 91. Hydromer Recent Development Table 92. Harland Medical Systems Company Information Table 93. Harland Medical Systems Business Overview Table 94. Harland Medical Systems Medical Antithrombotic Coatings Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 95. Harland Medical Systems Medical Antithrombotic Coatings Product Portfolio Table 96. Harland Medical Systems Recent Development Table 97. Coatings2Go Company Information Table 98. Coatings2Go Business Overview Table 99. Coatings2Go Medical Antithrombotic Coatings Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 100. Coatings2Go Medical Antithrombotic Coatings Product Portfolio Table 101. Coatings2Go Recent Development Table 102. Biocoat Company Information Table 103. Biocoat Business Overview Table 104. Biocoat Medical Antithrombotic Coatings Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 105. Biocoat Medical Antithrombotic Coatings Product Portfolio Table 106. Biocoat Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Medical Antithrombotic Coatings Distributors List Table 110. Medical Antithrombotic Coatings Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Medical Antithrombotic Coatings Product Image Figure 2. Global Medical Antithrombotic Coatings Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Antithrombotic Coatings Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medical Antithrombotic Coatings Sales (2021-2032) & (t) Figure 5. Global Medical Antithrombotic Coatings Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Medical Antithrombotic Coatings Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Phosphorylcholine Image Figure 10. PEG Coating Image Figure 11. Heparin Coating Image Figure 12. Other Image Figure 13. Global Medical Antithrombotic Coatings Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Medical Antithrombotic Coatings Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Medical Antithrombotic Coatings Sales Volume Share by Type (2021-2032) Figure 16. Global Medical Antithrombotic Coatings Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medical Antithrombotic Coatings Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Medical Antithrombotic Coatings Sales Value Share by Type (2021-2032) Figure 19. Medical Devices Image Figure 20. Hemodialysis Tubing Image Figure 21. Vascular Stents Image Figure 22. Other Image Figure 23. Global Medical Antithrombotic Coatings Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 24. Global Medical Antithrombotic Coatings Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Medical Antithrombotic Coatings Sales Volume Share by Application (2021-2032) Figure 26. Global Medical Antithrombotic Coatings Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Medical Antithrombotic Coatings Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Medical Antithrombotic Coatings Sales Value Share by Application (2021-2032) Figure 29. Global Medical Antithrombotic Coatings Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 30. Global Medical Antithrombotic Coatings Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Medical Antithrombotic Coatings Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Medical Antithrombotic Coatings Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Medical Antithrombotic Coatings Sales Value (2021-2032) & (US$ Million) Figure 34. North America Medical Antithrombotic Coatings Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Medical Antithrombotic Coatings Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Medical Antithrombotic Coatings Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Medical Antithrombotic Coatings Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Medical Antithrombotic Coatings Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Medical Antithrombotic Coatings Sales Value (2021-2032) & (US$ Million) Figure 40. South America Medical Antithrombotic Coatings Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Medical Antithrombotic Coatings Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Medical Antithrombotic Coatings Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Medical Antithrombotic Coatings Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Medical Antithrombotic Coatings Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Phosphorylcholine
  • PEG Coating
  • Heparin Coating
  • Other
Applications
  • Medical Devices
  • Hemodialysis Tubing
  • Vascular Stents
  • Other
Companies covered
  • Thermal Spray Technologies
  • Surmodics
  • Surface Solutions Group
  • Specialty Coating Systems (SCS)
  • Hydromer
  • Harland Medical Systems
  • Coatings2Go
  • Biocoat

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Antithrombotic Coatings Sales Value (2021-2032)
  4. 1.2.2 Global Medical Antithrombotic Coatings Sales Volume (2021-2032)
  5. 1.2.3 Global Medical Antithrombotic Coatings Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medical Antithrombotic Coatings Market Dynamics
  1. 2.1 Medical Antithrombotic Coatings Industry Trends
  2. 2.2 Medical Antithrombotic Coatings Industry Drivers
  3. 2.3 Medical Antithrombotic Coatings Industry Opportunities and Challenges
  4. 2.4 Medical Antithrombotic Coatings Industry Restraints
3 Medical Antithrombotic Coatings Market by Company
  1. 3.1 Global Medical Antithrombotic Coatings Company Revenue Ranking in 2025
  2. 3.2 Global Medical Antithrombotic Coatings Revenue by Company (2021-2026)
  3. 3.3 Global Medical Antithrombotic Coatings Sales Volume by Company (2021-2026)
  4. 3.4 Global Medical Antithrombotic Coatings Average Price by Company (2021-2026)
  5. 3.5 Global Medical Antithrombotic Coatings Company Ranking (2024-2026)
  6. 3.6 Global Medical Antithrombotic Coatings Company Manufacturing Base and Headquarters
  7. 3.7 Global Medical Antithrombotic Coatings Company Product Type and Application
  8. 3.8 Global Medical Antithrombotic Coatings Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medical Antithrombotic Coatings Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medical Antithrombotic Coatings Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medical Antithrombotic Coatings Market by Type
  1. 4.1 Medical Antithrombotic Coatings Type Introduction
  2. 4.1.1 Phosphorylcholine
  3. 4.1.2 PEG Coating
  4. 4.1.3 Heparin Coating
  5. 4.1.4 Other
  6. 4.2 Global Medical Antithrombotic Coatings Sales Volume by Type
  7. 4.2.1 Global Medical Antithrombotic Coatings Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medical Antithrombotic Coatings Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Medical Antithrombotic Coatings Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Medical Antithrombotic Coatings Sales Value by Type
  11. 4.3.1 Global Medical Antithrombotic Coatings Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Medical Antithrombotic Coatings Sales Value by Type (2021-2032)
  13. 4.3.3 Global Medical Antithrombotic Coatings Sales Value Share by Type (2021-2032)
5 Medical Antithrombotic Coatings Market by Application
  1. 5.1 Medical Antithrombotic Coatings Application Introduction
  2. 5.1.1 Medical Devices
  3. 5.1.2 Hemodialysis Tubing
  4. 5.1.3 Vascular Stents
  5. 5.1.4 Other
  6. 5.2 Global Medical Antithrombotic Coatings Sales Volume by Application
  7. 5.2.1 Global Medical Antithrombotic Coatings Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Medical Antithrombotic Coatings Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Medical Antithrombotic Coatings Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Medical Antithrombotic Coatings Sales Value by Application
  11. 5.3.1 Global Medical Antithrombotic Coatings Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Medical Antithrombotic Coatings Sales Value by Application (2021-2032)
  13. 5.3.3 Global Medical Antithrombotic Coatings Sales Value Share by Application (2021-2032)
6 Medical Antithrombotic Coatings Regional Sales and Value Analysis
  1. 6.1 Global Medical Antithrombotic Coatings Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Antithrombotic Coatings Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Antithrombotic Coatings Sales by Region: 2021-2026
  4. 6.2.2 Global Medical Antithrombotic Coatings Sales by Region (2027-2032)
  5. 6.3 Global Medical Antithrombotic Coatings Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medical Antithrombotic Coatings Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medical Antithrombotic Coatings Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medical Antithrombotic Coatings Sales Value by Region (2027-2032)
  9. 6.5 Global Medical Antithrombotic Coatings Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medical Antithrombotic Coatings Sales Value (2021-2032)
  12. 6.6.2 North America Medical Antithrombotic Coatings Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medical Antithrombotic Coatings Sales Value (2021-2032)
  15. 6.7.2 Europe Medical Antithrombotic Coatings Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medical Antithrombotic Coatings Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medical Antithrombotic Coatings Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medical Antithrombotic Coatings Sales Value (2021-2032)
  21. 6.9.2 South America Medical Antithrombotic Coatings Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medical Antithrombotic Coatings Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medical Antithrombotic Coatings Sales Value Share by Country, 2025 VS 2032
7 Medical Antithrombotic Coatings Country-level Sales and Value Analysis
  1. 7.1 Global Medical Antithrombotic Coatings Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Antithrombotic Coatings Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medical Antithrombotic Coatings Sales by Country (2021-2032)
  4. 7.3.1 Global Medical Antithrombotic Coatings Sales by Country (2021-2026)
  5. 7.3.2 Global Medical Antithrombotic Coatings Sales by Country (2027-2032)
  6. 7.4 Global Medical Antithrombotic Coatings Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medical Antithrombotic Coatings Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medical Antithrombotic Coatings Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medical Antithrombotic Coatings Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medical Antithrombotic Coatings Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medical Antithrombotic Coatings Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermal Spray Technologies
  2. 8.1.1 Thermal Spray Technologies Company Information
  3. 8.1.2 Thermal Spray Technologies Business Overview
  4. 8.1.3 Thermal Spray Technologies Medical Antithrombotic Coatings Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermal Spray Technologies Medical Antithrombotic Coatings Product Portfolio
  6. 8.1.5 Thermal Spray Technologies Recent Developments
  7. 8.2 Surmodics
  8. 8.2.1 Surmodics Company Information
  9. 8.2.2 Surmodics Business Overview
  10. 8.2.3 Surmodics Medical Antithrombotic Coatings Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Surmodics Medical Antithrombotic Coatings Product Portfolio
  12. 8.2.5 Surmodics Recent Developments
  13. 8.3 Surface Solutions Group
  14. 8.3.1 Surface Solutions Group Company Information
  15. 8.3.2 Surface Solutions Group Business Overview
  16. 8.3.3 Surface Solutions Group Medical Antithrombotic Coatings Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Surface Solutions Group Medical Antithrombotic Coatings Product Portfolio
  18. 8.3.5 Surface Solutions Group Recent Developments
  19. 8.4 Specialty Coating Systems (SCS)
  20. 8.4.1 Specialty Coating Systems (SCS) Company Information
  21. 8.4.2 Specialty Coating Systems (SCS) Business Overview
  22. 8.4.3 Specialty Coating Systems (SCS) Medical Antithrombotic Coatings Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Specialty Coating Systems (SCS) Medical Antithrombotic Coatings Product Portfolio
  24. 8.4.5 Specialty Coating Systems (SCS) Recent Developments
  25. 8.5 Hydromer
  26. 8.5.1 Hydromer Company Information
  27. 8.5.2 Hydromer Business Overview
  28. 8.5.3 Hydromer Medical Antithrombotic Coatings Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hydromer Medical Antithrombotic Coatings Product Portfolio
  30. 8.5.5 Hydromer Recent Developments
  31. 8.6 Harland Medical Systems
  32. 8.6.1 Harland Medical Systems Company Information
  33. 8.6.2 Harland Medical Systems Business Overview
  34. 8.6.3 Harland Medical Systems Medical Antithrombotic Coatings Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Harland Medical Systems Medical Antithrombotic Coatings Product Portfolio
  36. 8.6.5 Harland Medical Systems Recent Developments
  37. 8.7 Coatings2Go
  38. 8.7.1 Coatings2Go Company Information
  39. 8.7.2 Coatings2Go Business Overview
  40. 8.7.3 Coatings2Go Medical Antithrombotic Coatings Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Coatings2Go Medical Antithrombotic Coatings Product Portfolio
  42. 8.7.5 Coatings2Go Recent Developments
  43. 8.8 Biocoat
  44. 8.8.1 Biocoat Company Information
  45. 8.8.2 Biocoat Business Overview
  46. 8.8.3 Biocoat Medical Antithrombotic Coatings Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biocoat Medical Antithrombotic Coatings Product Portfolio
  48. 8.8.5 Biocoat Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Antithrombotic Coatings Value Chain Analysis
  2. 9.1.1 Medical Antithrombotic Coatings Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Antithrombotic Coatings Sales Mode & Process
  6. 9.2 Medical Antithrombotic Coatings Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Antithrombotic Coatings Distributors
  9. 9.2.3 Medical Antithrombotic Coatings Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst